DAS Capital team consists of experts from MedTech, pharmaceutical and diagnostic sectors plus strategic orientated, experienced, innovative transactionists. Together, they seamlessly contribute to M&A strategic planning, transaction initiation, transaction execution, and strategy deliberations for the clients.

Kevin Ren

Partner&CEO                : rz@dascapital.cn

Kevin Ren has more than 17 years of corporate finance, venture capital, mergers and acquisitions, and consulting experience.
Kevin is the CEO of DAS Capital, a boutique investment advisory firm specializing in the life science and healthcare sector.

Before starting DAS Capital, he was the partner in SMC Capital China (founded by Mr. Simon Murray, ex-Hutchison Whampoa MD, $2bn AUM).
Before that, he spent several years as a management consultant in L.E.K. Consulting, and working in the M&A team with CEMEX S.A.B. He earned his degrees from the University of Manchester and Tsinghua University.

Kevin has advised companies on billions of RMB private placements including HeartCare Medical (HK 6609), Sciwind (metabolic drug R&D), Nutshell (AI+allosteric drug platform), Shenqi Medical (cardiac intervention devices), and ForQaly (ventricular assist system) etc.

Che Jian

Partner                : cj@dascapital.cn

Mr. Che has more than 15 years of experience in private equity investment and financing.

Prior to joining DAS Capital, Mr. Che was a partner at Cygnus Equity, responsible for project mining and financing in the industrial, technology and enterprise service tracks, leading the financing of more than 30 projects and completing over 10 billion RMB of financing in total. He successfully completed the delivery of Souche, FITURE, Revopoint, Zhuiyi, Neolix, XKool, iMile, Huisuanzhang, Moka, Wangdiantong and other projects. He has worked for CID Investment, Greenwoods Investment, Oriental Fortune Capital and Providence Equity Partners, one of the world's largest private equity funds.

Mr. Che graduated from Shanghai Jiao Tong University with a Bachelor's degree in Engineering and a Master's degree in Management.

Werner Qiu

Managing Director               : wq@dascapital.cn

Werner Qiu has more than 12 years of experience in venture capital, management consulting, and sales & marketing in the healthcare industry.

Before joining DAS Capital, Werner worked at medical MNCs such as Boston Scientific, Abbott Laboratories, and Novartis. He was responsible for marketing, strategic planning, and channel management in China.

Later he worked as the head of medical device team at China Renaissance, assisting multiple well-known start-up enterprises in completing financing and accumulating profound industry qualifications and track experience. His representative cases such as Redpine, Insight Lifetech,  Vickor Medical, magAssist and Pulnovo Medical.

Werner graduated from the School of Medicine of Shanghai Jiao Tong University with a PhD in Pediatric Cardiology and a Bachelor's degree in Pharmacy.

Joyce Cao

Executive Director             : cfs@dascapital.cn

Joyce serves as executive director and oversees the operation of our middle office.

Prior to DAS Capital, she worked in Ernst & Young and has gained more than 8 years’ experience in private equity, investment banking, and consulting in healthcare and life sciences.

Joyce plays a dominant role in the strategic cooperation with clients such as HeartCare Medical (HKG: 6609), Shenqi Medical, and Nutshell Therapeutics.

She received her master's degree from Shanghai Jiao Tong University and bachelor's degree from Central University of Finance and Economics.

Joyce is also a Chinese Certified Public Accountant.

Anna Zou

Executive Director             : zln@dascapital.cn

Anna is our IR specialist and a senior consultant in the healthcare industry with more than 8 years’ professional experience.

Before joining DAS Capital, she served as senior project manager of a global primary research firm and then the IR Head of PhoenixTree Capital.

Since joining DAS Capital, Anna has been the key member of our ECM department and been well connected with institutional investors from private equity, venture capital, family offices and public-traded companies.

Her star cases include ForQaly, Nutshell Therapeutics, Pushkang Biotechnology , Sino - Biocan and CommBio Therapeutic, etc.

Anna earned her bachelor’s degree from Shanghai Ocean University.

Fiona Yang

Senior Vice President               : ywl@dascapital.cn

Fiona has nearly 10 years of experience in corporate finance and sales & marketing in the healthcare industry.

Since joining DAS Capital, Fiona has led and participated in multiple rounds of financing and strategic cooperation with companies such as Yiteng Medical, Weimu Medical, Rongsheng Medical, Shineyo Mesical, Sonosemi Medical, Rebeccatech and Hooke Instruments.

Before joining DAS Capital, Fiona worked as a product specialist at Medtronic and Johnson & Johnson Medical, responsible for marketing and sales in multiple departments and fields. She was familiar with business logic and cutting-edge trends in various tracks.

Fiona holds dual bachelor's degrees in Biotechnology and Economics from Fudan University.